UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 148

Sortiert nach

Does delayed EBV infection contribute to rising childhood cancers?

Trends in immunology, 2022-12, Vol.43 (12), p.956-958

2022

Volltextzugriff (PDF)

Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer

Cancer letters, 2017-06, Vol.396, p.155-166

2017

Volltextzugriff (PDF)

Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy

Clinical cancer research, 2022-10, Vol.28 (20), p.4363-4369

2022

Volltextzugriff (PDF)

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity

PloS one, 2013-07, Vol.8 (7), p.e67512-e67512

2013

Volltextzugriff (PDF)

Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis

The Journal of biological chemistry, 2014-09, Vol.289 (36), p.24832-24844

2014

Volltextzugriff (PDF)

Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids

Experimental dermatology, 2015-08, Vol.24 (8), p.591-597

2015

Volltextzugriff (PDF)

Potent and long‐term antiangiogenic efficacy mediated by FP3‐expressing oncolytic adenovirus

International journal of cancer, 2015-11, Vol.137 (9), p.2253-2269

2015

Volltextzugriff (PDF)

A novel three-dimensional model system for keloid study: Organotypic multicellular scar model

Wound repair and regeneration, 2013-01, Vol.21 (1), p.155-165

2013

Volltextzugriff (PDF)

Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model

Clinical cancer research, 2006-10, Vol.12 (19), p.5859-5868

2006

Volltextzugriff (PDF)

Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166]

Cancer letters, 2017-09, Vol.404, p.93-93

2017

Volltextzugriff (PDF)

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

Nature (London), 2021-02, Vol.590 (7844), p.157-162

2021

Volltextzugriff (PDF)

CD4 + cytotoxic T cells: an emerging effector arm of anti-tumor immunity

BMB Reports, 2023-03, Vol.56 (2), p.140-144

2023

Volltextzugriff (PDF)

Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4⁺ and CD8⁺ T cell responses

Proceedings of the National Academy of Sciences - PNAS, 2018-01, Vol.115 (4), p.E686-E695

2018

Volltextzugriff (PDF)

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model

Oncotarget, 2017-01, Vol.8 (3), p.4730-4746

2017

Volltextzugriff (PDF)

Animal models for dengue vaccine development and testing

Clinical and Experimental Vaccine Research , 2017, 6(2), , pp.104-110

2017

Volltextzugriff (PDF)

Combination of Radiotherapy and Adenovirus-Mediated p53 Gene Therapy for MDM2-Overexpressing Hepatocellular Carcinoma

JOURNAL OF RADIATION RESEARCH, 2012, Vol.53 (2), p.202-210

2012

Volltextzugriff (PDF)

Proproliferative Functions of Drosophila Small Mitochondrial Heat Shock Protein 22 in Human Cells

The Journal of biological chemistry, 2010-02, Vol.285 (6), p.3833-3839

2010

Volltextzugriff (PDF)

Strategies to increase drug penetration in solid tumors

Frontiers in oncology, 2013-01, Vol.3, p.193-193

2013

Volltextzugriff (PDF)

Augmentation of rat skin flap viability by relaxin-expressing adenovirus

Wound repair and regeneration, 2011-11, Vol.19 (6), p.709-717

2011

Volltextzugriff (PDF)

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF

Molecular therapy, 2011-08, Vol.19 (8), p.1558-1568

2011

Volltextzugriff (PDF)

Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8), p.2598-2607

2013

Volltextzugriff (PDF)

Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL

Molecular therapy, 2010-02, Vol.18 (2), p.264-274

2010

Volltextzugriff (PDF)

Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

Mathematical biosciences and engineering : MBE, 2015-08, Vol.12 (4), p.841

2015

Volltextzugriff (PDF)

Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections

Mathematical biosciences and engineering : MBE, 2015-12, Vol.12 (6), p.1237

2015

Volltextzugriff (PDF)

Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in vitro experiments

Plastic and reconstructive surgery (1963), 2012-09, Vol.130 (3), p.407e-417e

2012

Volltextzugriff (PDF)

1 – 25 von 148

Suche als RSS-Feed

Aktive Filter

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(131)

Publikationsform

Sprache

Englisch
(104)
Koreanisch
(43)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(75)
Life Sciences & Biomedicine
(38)
Technology
(29)
Humans
(26)
Physical Sciences
(21)
Animals
(19)
Materials Science
(15)
Chemistry
(13)
Materials Science, Multidisciplinary
(13)
Physics
(13)
Adenovirus
(12)
Male
(12)
Cell Line, Tumor
(11)
Cytotoxicity
(11)
Engineering
(11)
Mice
(11)
Adenoviridae - Genetics
(10)
Oncology
(10)
Physics, Applied
(10)
Adenoviruses
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Does delayed EBV infection contribute to rising childhood cancers?

Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer

Facts and Hopes in the Relationship of EBV with Cancer Immunity and Immunotherapy

Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity

Identification and Functional Characterization of Nuclear Mortalin in Human Carcinogenesis

Decorin-expressing adenovirus decreases collagen synthesis and upregulates MMP expression in keloid fibroblasts and keloid spheroids

Potent and long‐term antiangiogenic efficacy mediated by FP3‐expressing oncolytic adenovirus

A novel three-dimensional model system for keloid study: Organotypic multicellular scar model

Enhanced Antitumor Effect of Oncolytic Adenovirus Expressing Interleukin-12 and B7-1 in an Immunocompetent Murine Model

Corrigendum to “Oncolytic adenovirus expressing relaxin (YDC002) enhances therapeutic efficacy of gemcitabine against pancreatic cancer” [Cancer Lett. 396 (2017) 155–166]

Mechanism of EBV inducing anti-tumour immunity and its therapeutic use

CD4 + cytotoxic T cells: an emerging effector arm of anti-tumor immunity

Signaling by the Epstein–Barr virus LMP1 protein induces potent cytotoxic CD4⁺ and CD8⁺ T cell responses

Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model

Animal models for dengue vaccine development and testing

Combination of Radiotherapy and Adenovirus-Mediated p53 Gene Therapy for MDM2-Overexpressing Hepatocellular Carcinoma

Proproliferative Functions of Drosophila Small Mitochondrial Heat Shock Protein 22 in Human Cells

Strategies to increase drug penetration in solid tumors

Augmentation of rat skin flap viability by relaxin-expressing adenovirus

Optimizing DC Vaccination by Combination With Oncolytic Adenovirus Coexpressing IL-12 and GM-CSF

Ex Vivo Expansion of Highly Cytotoxic Human NK Cells by Cocultivation with Irradiated Tumor Cells for Adoptive Immunotherapy

Therapeutic and Tumor-specific Immunity Induced by Combination of Dendritic Cells and Oncolytic Adenovirus Expressing IL-12 and 4-1BBL

Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics

Treatment strategies for combining immunostimulatory oncolytic virus therapeutics with dendritic cell injections

Relaxin-expressing adenovirus decreases collagen synthesis and up-regulates matrix metalloproteinase expression in keloid fibroblasts: in vitro experiments

Aktive Filter

Suchergebnisse filtern